Solid Biosciences's market cap is currently $211.76M. The company's EPS TTM is $-3.036; its P/E ratio is ―; Solid Biosciences is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 8.09M	$ 13.62M	$ 0.00	$ 0.00
Gross Profit	$ -76.56M	$ 5.69M	$ -45.12M	$ -3.92M	$ -2.82M
Operating Income	$ -104.31M	$ -106.45M	$ -72.25M	$ -88.41M	$ -119.32M
EBITDA	$ -93.43M	$ -96.87M	$ -69.29M	$ -84.37M	$ -116.49M
Net Income	$ -96.02M	$ -65.51M	$ -72.12M	$ -90.12M	$ -115.64M
Balance Sheet
Cash & Short-Term Investments	$ 123.64M	$ 213.72M	$ 207.78M	$ 154.74M	$ 83.52M
Total Assets	$ 164.94M	$ 260.25M	$ 232.38M	$ 171.17M	$ 103.47M
Total Debt	$ 26.27M	$ 28.55M	$ 2.06M	$ 5.15M	$ 7.07M
Net Debt	$ -47.75M	$ -126.84M	$ -117.07M	$ -149.59M	$ -68.97M
Total Liabilities	$ 38.46M	$ 48.59M	$ 24.17M	$ 39.08M	$ 23.42M
Stockholders' Equity	$ 126.48M	$ 211.67M	$ 208.21M	$ 132.09M	$ 80.05M
Cash Flow
Free Cash Flow	$ -95.69M	$ -100.99M	$ -79.05M	$ -57.50M	$ -97.10M
Operating Cash Flow	$ -94.18M	$ -97.98M	$ -77.76M	$ -56.60M	$ -92.71M
Investing Cash Flow	$ 9.69M	$ 59.16M	$ -91.09M	$ 6.60M	$ 24.52M
Financing Cash Flow	$ 3.12M	$ 74.83M	$ 134.99M	$ 128.70M	$ 57.88M

Currency in USD

Solid Biosciences Earnings and Revenue History

Income Statement >

Solid Biosciences Debt to Assets

Balance Sheet >

Solid Biosciences Cash Flow

Cash Flow >

Solid Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing